24 June 2026 : Clinical Research
Threonine in Coronary Artery Disease: Insights From Metabolic Syndrome Amino Acid Profiling
Tomasz Urbanowicz
ACDE 1*, Dagmara Pietkiewicz CDEF 2, Szymon Plewa CD 2, Beata Krasińska BCF 3, Jan Matysiak BCDE 2, Andrzej Tykarski BF 3
DOI: 10.12659/MSM.951571
Med Sci Monit 2026; 32:e951571
Figure 1 Differences in threonine concentration between analyzed groups. 1 – no MeS+no CAD (n=26); 2 – MeS+no CAD (n=10);3 – no MeS+CAD (n=14);4 – MeS+CAD (n=15). Significant differences noted between groups: 1–3 (P=0.039), 1–4 (P=0.030), 2–3 (P=0.040), 2–4 (P=0.048). CAD – coronary artery disease; MeS – metabolic syndrome.